Skip to NavigationSkip to content

Pharmafile - News News

Novartis has agreed to buy the rights for a novel antibody MOR106 from the Belgo-Dutch pharmaceutical research company Galapagos and the German...
In response to Donald Trump’s plan to lower drug prices in the US, the Pharmaceutical Research and Manufacturers of America (PhRMA) have proposed a...
British MPs have voted for the UKs continued participation in the regulatory network operated by the European Medicines Agency (EMA) after Brexit.
Microsoft business magnate Bill Gates has joined a coalition of philanthropists in committing more than $30 million towards the development of an...
Janssen has announced that Symtuza has received approval from the FDA in the treatment of HIV-1, making it the first and only darunavir-based single...
The Anglo-Swedish drug giant AstraZeneca is set to increase its stockpile of drugs in both the United Kingdom and the European Union in preparation...
Following US pharma giant Pfizer’s clash with President Donald Trump after it was called out on Twitter for hiking the prices of 100 of its...
A study published by researchers at McLean Hospital in Belmont, Massachusetts has led to the development of a statistical algorithm that is able to...
AbbVie and Mylan have announced that they have both signed a licensing agreement for the former’s proposed biosimilar version of the latter’s...
Leading geneticist and cancer researcher, Nazneen Rahman CBE, has resigned from her position as head of Genetics and Epidemiology at the London-...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches